Summary:
A double-blind, randomized, placebo-controlled, parallel-group withdrawal study of the efficacy and safety of delayed-release Rabeprazole for symptomatic/erosive GERD.
Qualified Participants Must:
• Be 1-11 months old
•
Have suspected/symptomatic or proven GERD
•
Not have a confirmed cow's milk allergy
Qualified Participants May Receive:
All study related medications, all study related medical care at no cost and compensation for time and travel.